Thoratec Set To Accept St. Jude Acquisition Offer As Go Shop Period Ends
This article was originally published in Clinica
Executive Summary
St. Jude Medical is on track to acquire ventricular assist device-maker Thoratec in the fourth quarter of 2015, now that the "go shop" period specified in the merger agreement has ended.
You may also be interested in...
Abbott Denies St. Jude Acquisition Report, But Here's How The Firms Line Up
A media report stating Abbott was readying to buy St. Jude Medical was quickly shot down by the company. The firms do, though, have relatively complementary product portfolios
VADs Set To Enter Big Leagues With St. Jude's Plan To Acquire Thoratec
St. Jude Medical says it will pay $3.4 billion to own ventricular-assist device leader Thoratec, pointing to significant synergies in the heart failure and interventional cardiology markets. The deal would thrust VADs into a diversified cardiology firm for the first time, and it includes a "go-shop" period that leaves an opening for other big device firms to enter competing bids.
News We’re Watching: FDA Approves Medtronic's Affera, Roche's CGM Moves Closer To Approval, And More
Medtech Insight's News We're Watching covers medtech industry and research news you may have missed. This week, the Advanced Technologies and Treatments for Diabetes (ATTD) conference in Florence, Italy, included new results from studies of Roche's continuous glucose monitor and Medtronic's 780G insulin pump, Medtronic moved closer to earning FDA approval for its Affera ablation mapping and ablation system, and Linus Health expanded its technology for finding signs of cognitive problems in speech data.